Bank CEOs meet with Trump to discuss Fannie Mae and Freddie Mac - Bloomberg
Hugh E. Sawyer III, a director at Huron Consulting Group Inc. (NASDAQ:HURN), a $2.25 billion consulting firm that has delivered an impressive 47% return over the past year, has sold 400 shares of the company’s common stock. The shares were sold at a price of $144.92 each, resulting in a total transaction value of approximately $57,967. Following this transaction, Sawyer holds 24,598 shares in the company. The sale was conducted automatically under a Rule 10b5-1 trading plan that Sawyer established on March 6, 2025. According to InvestingPro, the company maintains a "GREAT" financial health score, with management actively buying back shares. The stock is currently trading near its Fair Value, with 8 more exclusive insights available to Pro subscribers.
In other recent news, Huron Consulting Group reported impressive financial results for the first quarter of 2025, exceeding analysts’ expectations. The company achieved an earnings per share (EPS) of $1.68, significantly surpassing the forecasted $1.16, alongside revenue of $395.7 million, which also exceeded the anticipated $389.27 million. Huron’s revenue increased by 11.2% year-over-year, driven by growth across all operating segments, with the healthcare segment showing a 10% rise in revenue. The company reaffirmed its full-year guidance for 2025, projecting revenue between $1.58 billion and $1.66 billion.
Additionally, Huron Consulting announced the approval of an amendment to its Amended and Restated 2012 Omnibus Incentive Plan, increasing authorized shares by 900,000. This decision was made during the company’s Annual Meeting, where stockholders also approved executive compensation and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2025. Furthermore, Benchmark analysts reaffirmed their Buy rating for Huron Consulting, maintaining a $165.00 price target, citing a stable outlook and positive impact from recent government actions.
Huron Consulting is experiencing strong demand in its Healthcare segment, particularly in Revenue Cycle Management projects, as clients face financial pressures. The company also reported increased sales conversions in this area. Recent discussions with clients have focused on adapting to potential regulatory changes, including proposed caps on NIH funding and Medicare payment cuts. Despite these challenges, Huron’s strategic approach and market adaptability continue to drive its growth and maintain investor confidence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.